Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes.
Saved in:
| Title: | Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes. |
|---|---|
| Authors: | Kidman J; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, University of Western Australia, Perth, Australia., Zemek RM; Telethon Kids Institute, Perth, Australia., Sidhom JW; Icahn School of Medicine, Mt Sinai Hospital, New York, USA., Correa D; Complex Systems Group, Department of Mathematics and Statistics, University of Western Australia, Perth, Australia., Principe N; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, University of Western Australia, Perth, Australia., Sheikh F; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, University of Western Australia, Perth, Australia., Fear VS; Telethon Kids Institute, Perth, Australia., Forbes CA; Telethon Kids Institute, Perth, Australia., Chopra A; Medical Genomics Laboratories (IIID), Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, Australia., Boon L; JJP Biologics, Warsaw, Poland., Zaitouny A; Complex Systems Group, Department of Mathematics and Statistics, University of Western Australia, Perth, Australia.; Department of Mathematical Sciences, United Arab Emirates University, Al Ain, United Arab Emirates., de Jong E; Telethon Kids Institute, Perth, Australia.; Medical School, University of Western Australia, Perth, Australia., Holt RA; BC Cancer Research Institute, Vancouver, Canada., Jones M; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Australia., Millward MJ; Medical School, University of Western Australia, Perth, Australia., Lassmann T; Telethon Kids Institute, Perth, Australia., Forrest ARR; Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Australia., Nowak AK; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, University of Western Australia, Perth, Australia.; Medical School, University of Western Australia, Perth, Australia., Watson M; Medical Genomics Laboratories (IIID), Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, Australia., Lake RA; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, University of Western Australia, Perth, Australia., Lesterhuis WJ; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, University of Western Australia, Perth, Australia.; Telethon Kids Institute, Perth, Australia., Chee J; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, University of Western Australia, Perth, Australia. |
| Source: | Oncoimmunology [Oncoimmunology] 2024 Apr 26; Vol. 13 (1), pp. 2345859. Date of Electronic Publication: 2024 Apr 26 (Print Publication: 2024). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
